Menu
GWAS Study

A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.

Edwards TL, Giri A, Hellwege JN et al.

31249589 PubMed ID
GWAS Study Type
230274 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ET
Edwards TL
GA
Giri A
HJ
Hellwege JN
HK
Hartmann KE
SE
Stewart EA
JJ
Jeff JM
BM
Bray MJ
PS
Pendergrass SA
TE
Torstenson ES
KJ
Keaton JM
JS
Jones SH
GR
Gogoi RP
KH
Kuivaniemi H
JK
Jackson KL
KA
Kho AN
KI
Kullo IJ
MC
McCarty CA
IH
Im HK
PJ
Pacheco JA
PJ
Pathak J
WM
Williams MS
TG
Tromp G
KE
Kenny EE
PP
Peissig PL
DJ
Denny JC
RD
Roden DM
VE
Velez Edwards DR
Chapter II

Abstract

Summary of the research findings

Uterine fibroids affect up to 77% of women by menopause and account for up to $34 billion in healthcare costs each year. Although fibroid risk is heritable, genetic risk for fibroids is not well understood. We conducted a two-stage case-control meta-analysis of genetic variants in European and African ancestry women with and without fibroids classified by a previously published algorithm requiring pelvic imaging or confirmed diagnosis. Women from seven electronic Medical Records and Genomics (eMERGE) network sites (3,704 imaging-confirmed cases and 5,591 imaging-confirmed controls) and women of African and European ancestry from UK Biobank (UKB, 5,772 cases and 61,457 controls) were included in the discovery genome-wide association study (GWAS) meta-analysis. Variants showing evidence of association in Stage I GWAS (P < 1 × 10-5) were targeted in an independent replication sample of African and European ancestry individuals from the UKB (Stage II) (12,358 cases and 138,477 controls). Logistic regression models were fit with genetic markers imputed to a 1000 Genomes reference and adjusted for principal components for each race- and site-specific dataset, followed by fixed-effects meta-analysis. Final analysis with 21,804 cases and 205,525 controls identified 326 genome-wide significant variants in 11 loci, with three novel loci at chromosome 1q24 (sentinel-SNP rs14361789; P = 4.7 × 10-8), chromosome 16q12.1 (sentinel-SNP rs4785384; P = 1.5 × 10-9) and chromosome 20q13.1 (sentinel-SNP rs6094982; P = 2.6 × 10-8). Our statistically significant findings further support previously reported loci including SNPs near WT1, TNRC6B, SYNE1, BET1L, and CDC42/WNT4. We report evidence of ancestry-specific findings for sentinel-SNP rs10917151 in the CDC42/WNT4 locus (P = 1.76 × 10-24). Ancestry-specific effect-estimates for rs10917151 were in opposite directions (P-Het-between-groups = 0.04) for predominantly African (OR = 0.84) and predominantly European women (OR = 1.16). Genetically-predicted gene expression of several genes including LUZP1 in vagina (P = 4.6 × 10-8), OBFC1 in esophageal mucosa (P = 8.7 × 10-8), NUDT13 in multiple tissues including subcutaneous adipose tissue (P = 3.3 × 10-6), and HEATR3 in skeletal muscle tissue (P = 5.8 × 10-6) were associated with fibroids. The finding for HEATR3 was supported by SNP-based summary Mendelian randomization analysis. Our study suggests that fibroid risk variants act through regulatory mechanisms affecting gene expression and are comprised of alleles that are both ancestry-specific and shared across continental ancestries.

8,168 European ancestry cases, 65,134 European ancestry controls, 1,278 African ancestry cases, 1,914 African ancestry controls

Chapter III

Study Statistics

Key metrics and study information

230274
Total Participants
GWAS
Study Type
Yes
Replicated
12,111 European ancestry cases, 138,477 European ancestry controls, 247 African ancestry cases, 713 African ancestry controls
Replication Participants
African unspecified, European, African unspecified, African American or Afro-Caribbean
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.